4-(2-nitro-5-piperazin-1-ylphenyl)morpholine,
332023-13-9,
4-[2-NITRO-5-(1-PIPERAZINYL)PHENYL]MORPHOLINE,
4-(2-Nitro-5-(piperazin-1-yl)phenyl)morpholine,
4-(2-Nitro-5-piperazin-1-yl-phenyl)-morpholine,
4-[2-nitro-5-(piperazin-1-yl)phenyl]morpholine,
4-(2-nitro-5-piperazinylphenyl)morpholine,
BAS 00805348,
AC1MCJX1,
Cambridge id 5764926,
Oprea1_601494,
CTK4H0152,
TOS-BB-0567,
DTXSID70377938,
ALBB-024849,
ZINC4561403,
ZX-CM016154,
BBL002980,
MFCD01173869,
SBB072147,
STK019728,
AKOS000288815,
MCULE-2894588743,
ACM332023139,
AJ-51679,
ST095710,
AB0221540,
BB 0245821,
FT-0708895,
W-8087,
AB00096188-01,
4-(2-Nitro-5-piperazin-1-yl-phenyl)-morpholin e,
SR-01000421718,
SR-01000421718-1,
morpholine, 4-[2-nitro-5-(1-piperazinyl)phenyl]-, hydrochloride,
4- morpholine,
CID2771409,